Nuvation Bio Inc.

This study is testing a new drug called AB-106 for people with advanced non-small cell lung cancer that has a specific genetic change called ROS1 fusion. The goal is to see if the drug is safe and effective at controlling the cancer. Participants take the drug daily in repeating …

This program provided access to the experimental drug taletrectinib for patients with advanced ROS1-positive lung cancer who had run out of approved treatment options and couldn't join regular clinical trials. The program was designed for people whose cancer had spread and who co…

This study is testing a new drug called NUV-1511 in adults with advanced solid tumors that have stopped responding to standard treatments. The first part checks the drug's safety and finds the right dose, while the second part looks at how well it shrinks tumors in specific cance…

This study is testing an oral medication called taletrectinib for people with advanced lung cancer that has a specific genetic change called ROS1. The trial aims to see how well the drug shrinks tumors and how safe it is for patients, including those who have or haven't had simil…